%0 Journal Article
%T The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostat
%A Jane B. Trepel
%A Min-Jung Lee
%A Peter Ordentlich
%A Saori Tomita
%A Saranya Chumsri
%A Scott Cruickshank
%A Sunmin Lee
%A Yusuke Tomita
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2016.1219008
%K Breast cancer
%K entinostat
%K exemestane
%K histone deacetylase inhibitors
%K HLA-DR
%K immune checkpoint receptor
%K immune subsets
%K monocyte
%K myeloid-derived suppressor cell
%K regulatory T cell
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139687/